The Senator accused Bancel of lying about the incidence of myocarditis in vaccine recipients, particularly in young males.
In a recent Senate hearing, Senator Rand Paul confronted Moderna CEO Stephane Bancel about the safety and efficacy of the Moderna COVID-19 vaccine. The Senator accused Bancel of lying about the incidence of myocarditis in vaccine recipients, particularly in young males.
According to Senator Paul, Moderna paid the NIH $400 million in royalties last year for the use of technology related to developing the COVID-19 vaccine.
Senator Paul argued that the payments created a financial incentive for the NIH to promote the use of the Moderna vaccine, even if it was not in the best interest of public health.
Watch the full video over here.
The role of financial incentives and conflicts of interest in developing and promoting medical treatments has long been controversial and debated. Critics argue that financial incentives can create conflicts of interest that undermine public trust and compromise the integrity of medical research and decision-making.
Proponents of the system, however, argue that financial incentives are necessary to incentivize research and development of new treatments and therapies, and that proper safeguards and oversight can help mitigate potential conflicts of interest.
According to the Centers for Disease Control and Prevention (CDC), the risk of myocarditis following the second dose of the Pfizer or Moderna vaccine is estimated to be between 1 in 5,000 and 1 in 20,000.
Myocarditis is an inflammation of the heart muscle that can cause chest pain, shortness of breath, and in severe cases, heart failure. There have been reports of myocarditis in young males receiving the COVID-19 vaccine, particularly after the second dose.
During the hearing, Senator Paul asked Bancel whether the risk of myocarditis was less common in those who had received the vaccine than in those who had contracted the virus. Bancel responded that it was his understanding that the risk of myocarditis was less common in vaccine recipients, which Senator Paul vehemently disputed.
Senator Paul cited six peer-reviewed papers contradicting Bancel's claims and entered them into the record.
He also mentioned that he had spoken with Moderna's president, who had privately acknowledged that there was an increased risk of myocarditis associated with the vaccine.
@SenRandPaul Said :
: "All of the Studies isolate out people by age, have found that, YES, there's an increased risk [of myocarditis] after taking your vaccine."
MODERNA CEO: "That was comparing it to someone who gets COVID."
PAUL: "Well, that's also not true either."
Watch the full video here:
The exchange between Senator Paul and Bancel highlights the ongoing debate around the safety and efficacy of COVID-19 vaccines, particularly in young people. While the vaccines have been proven to be highly effective in preventing severe illness and hospitalization, there have been reports of side effects, including myocarditis.
However, it is important to note that the incidence of myocarditis following the COVID-19 vaccine is still relatively rare. According to the Centers for Disease Control and Prevention (CDC), the risk of myocarditis following the second dose of the Pfizer or Moderna vaccine is estimated to be between 1 in 5,000 and 1 in 20,000.
The CDC recommends that individuals who experience chest pain, shortness of breath, or feelings of having a fast-beating, fluttering, or pounding heart within a few days after vaccination seek medical care immediately.
What are your thoughts on this? Are we getting to know more risks and things that have happened?
Comments / 457